The survey also found high rates of alternative funding programs, controversial arrangements in which employers outsource access to pricey specialty drugs to third parties.Dive Brief:More than half of adults with commercial insurance were informed by their plan that it would no longer cover their medications for a chronic or rare disease, according to a new […]
